Search Results - "Singh, Jasvinder A"

Refine Results
  1. 1

    Rates of Total Joint Replacement in the United States: Future Projections to 2020-2040 Using the National Inpatient Sample by Singh, Jasvinder A, Yu, Shaohua, Chen, Lang, Cleveland, John D

    Published in Journal of rheumatology (01-09-2019)
    “…To project future total hip and knee joint arthroplasty (THA, TKA) use in the United States to 2040. We used the 2000-2014 US National Inpatient Sample (NIS)…”
    Get full text
    Journal Article
  2. 2

    “I wish it had a place to go”: a nominal group study of barriers to the effectiveness of non-surgical treatments for knee osteoarthritis inclusive of minority populations by Singh, Jasvinder A

    Published in Arthritis research & therapy (01-12-2021)
    “…Abstract Objective To examine patient experience, views, and opinions regarding the ineffectiveness of the current knee osteoarthritis (OA) treatments. Methods…”
    Get full text
    Journal Article
  3. 3

    The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases by Singh, Jasvinder A.

    “…Janus kinase inhibitor (JAKi) medications are small-molecule drugs that affect intracellular signal transduction. They are highly effective oral medications…”
    Get full text
    Journal Article
  4. 4

    Total Knee Arthroplasty Volume, Utilization, and Outcomes Among Medicare Beneficiaries, 1991-2010 by Cram, Peter, Lu, Xin, Kates, Stephen L, Singh, Jasvinder A, Li, Yue, Wolf, Brian R

    “…CONTEXT Total knee arthroplasty (TKA) is one of the most common and costly surgical procedures performed in the United States. OBJECTIVE To examine…”
    Get full text
    Journal Article
  5. 5

    Anakinra for Rheumatoid Arthritis: A Systematic Review by MERTENS, Marty, SINGH, Jasvinder A

    Published in Journal of rheumatology (01-06-2009)
    “…Objective. To perform a systematic review of clinical effectiveness and safety of anakinra in rheumatoid arthritis (RA). Methods. We searched Cochrane Central…”
    Get full text
    Journal Article
  6. 6

    National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality by Singh, Jasvinder A, Cleveland, John D

    Published in PloS one (18-02-2020)
    “…The opioid epidemic is a major public health crisis in the U.S. Contemporary data on opioid use disorder (OUD) related hospitalizations are needed. Our…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care by Curtis, Jeffrey R., MD, MPH, Singh, Jasvinder A., MD, MPH

    Published in Clinical therapeutics (01-06-2011)
    “…Abstract Background Improved understanding of rheumatoid arthritis (RA) pathogenesis has led to the development of new biologic treatments that target specific…”
    Get full text
    Journal Article
  13. 13
  14. 14

    The burden of septic arthritis on the U.S. inpatient care: A national study by Singh, Jasvinder A, Yu, Shaohua

    Published in PloS one (15-08-2017)
    “…To assess the health care burden of septic arthritis in the U.S. and examine the associated factors. We used the U.S. Nationwide Emergency Department Sample…”
    Get full text
    Journal Article
  15. 15

    Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 by Boers, Maarten, Kirwan, John R, Wells, George, Beaton, Dorcas, Gossec, Laure, d'Agostino, Maria-Antonietta, Conaghan, Philip G, Bingham, Clifton O, Brooks, Peter, Landewé, Robert, March, Lyn, Simon, Lee S, Singh, Jasvinder A, Strand, Vibeke, Tugwell, Peter

    Published in Journal of clinical epidemiology (01-07-2014)
    “…Abstract Background Lack of standardization of outcome measures limits the usefulness of clinical trial evidence to inform health care decisions. This can be…”
    Get full text
    Journal Article
  16. 16

    SToRytelliing to Improve Disease outcomes in Gout (STRIDE-GO) in African American veterans with gout: a trial study protocol by Singh, Jasvinder A

    “…Medication adherence in gout is suboptimal, and the lack of effective interventions to address it presents a huge challenge. Medication adherence and gout…”
    Get full text
    Journal Article
  17. 17

    The HOME Core outcome set for clinical trials of atopic dermatitis by Williams, Hywel C., Schmitt, Jochen, Thomas, Kim S., Spuls, Phyllis I., Simpson, Eric L., Apfelbacher, Christian J., Chalmers, Joanne R., Furue, Masutaka, Katoh, Norito, Gerbens, Louise A.A., Leshem, Yael A., Howells, Laura, Singh, Jasvinder A., Boers, Maarten

    Published in Journal of allergy and clinical immunology (01-06-2022)
    “…Core outcome sets are critically important outcomes that should be measured in clinical trials. Their absence in atopic dermatitis is a form of research waste…”
    Get full text
    Journal Article
  18. 18

    Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims by Singh, Jasvinder A, Yu, Shaohua

    Published in Arthritis research & therapy (22-09-2016)
    “…Previous observational studies that have examined the association of allopurinol with myocardial infarction (MI) have provided contradictory results. One study…”
    Get full text
    Journal Article
  19. 19
  20. 20